Nuwellis' Aquadex SmartFlow® System is designed to remove excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. The RenalSense Clarity RMS is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to medical staff. Nuwellis consists of a purpose-driven team that puts patients and their providers at the center of everything they do. The company is headquartered in Eden Prairie, Minn., with a wholly-owned subsidiary in Ireland and has been listed on the Nasdaq Capital Market since February 2012.